Singapore markets close in 7 hours 4 minutes

ABBV Jan 2024 160.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
8.55-0.10 (-1.16%)
As of 03:19PM EST. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    3 Reasons to Buy AbbVie and 2 Reasons Not to Buy

    2023 is expected to be an important year for AbbVie (NYSE: ABBV). The pharmaceutical company is facing its first biosimilar competition in the United States. It's big news because it involves AbbVie's monoclonal antibody blockbuster therapy, Humira, which is on track to generate a second consecutive year of $20 billion-plus in revenue in 2022.

  • Motley Fool

    Want Safety and Growth in 2023? Try These Dividend Stocks.

    Last year was a tough one for most companies and investors. The three major indexes touched bear territory. And even the strongest of companies saw their share prices slip. Everyone is hoping 2023 will bring better days.

  • Zacks

    AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

    In the latest trading session, AbbVie (ABBV) closed at $148.55, marking a -0.7% move from the previous day.